Presentation is loading. Please wait.

Presentation is loading. Please wait.

Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116.

Published byMarsha Craig Modified over 9 years ago

Similar presentations

Presentation on theme: "Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116."— Presentation transcript:

1 Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116 p53 -/- 89.5189.9 MCF715.6127.2 R 2 value0.394

2 ** Knight et al – Supplementary Figure 1 AROS 2 siRNA Mock Fold apoptosis induction SIRT1 siRNA AROS 1 siRNA + ++ + -- -- AB n.s.

3 Knight et al – Supplementary Figure 2 mRNA expression (%) siRNA HCT116 mRNA expression (%) siRNA HCT116 p53 -/- mRNA expression (%) siRNA MCF7 mRNA expression (%) siRNA WI-38 mRNA expression (%) siRNA MCF10A Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA Lamin AC mRNA SIRT1 mRNA AROS mRNA

4 Mock SIRT1 AROS siRNA Fold apoptosis vs. Mock *** Etoposide and TSA *** Mock AROS SIRT1 UV-C irradiation Knight et al – Supplementary Figure 3 Condition β-actin K382Ac Treatment p53 Etoposide and TSA UV-CControl * 37kDa 50kDa A B

Download ppt "Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116."

Similar presentations

Supplemental Figure 1 A No. at risk T3 530 483 304 185 50 T2 559 545 373 228 76 T1 540 532 375 208 64.

Supplemental Figure 1 A No. at risk T T T
Tfam 1  g empty vector 1  g Tfb2m 1  g Relative mRNA level 0 100 200 50 150 * * p

Tfam 1  g empty vector 1  g Tfb2m 1  g Relative mRNA level * * p
Figure S1 A P

Figure S1 A P
Figure 1 HuR Tis11b HPRT VEGF 0 1 2 3 4 5Time (h) A 462 bp (VEGF 165 ) 332 bp (VEGF 121 ) 354 bp 111 bp 305 bp.

Figure 1 HuR Tis11b HPRT VEGF Time (h) A 462 bp (VEGF 165 ) 332 bp (VEGF 121 ) 354 bp 111 bp 305 bp.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.

Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.
Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.

Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.
Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.

Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.
Supplemental Figure S1: Diagram to show previously reported interactions between EGFR and 23 other Egr1 target genes using Pathway Studio, Ariadne Inc.

Supplemental Figure S1: Diagram to show previously reported interactions between EGFR and 23 other Egr1 target genes using Pathway Studio, Ariadne Inc.
Supplementary Figure 1A-B A H1299 RH1299 0 15 30 45 60 0 45 80 160 200 LC3-I / II P-GSK-3 (Ser21/9) GSK-3α/β β-actin β-catenine P-GSK-3 (Tyr279/216) B.

Supplementary Figure 1A-B A H1299 RH LC3-I / II P-GSK-3 (Ser21/9) GSK-3α/β β-actin β-catenine P-GSK-3 (Tyr279/216) B.
Supplementary Figure 1. Suzuki et al. DAPI/BrdU BrdU 24 hrs 48 hrs 72 hrs.

Supplementary Figure 1. Suzuki et al. DAPI/BrdU BrdU 24 hrs 48 hrs 72 hrs.
Supplemental Table 1 Source and authentication of cell lines.

Supplemental Table 1 Source and authentication of cell lines.
Figure S1 0 1 2 3 4 UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *

Figure S UV- UV+ Relative expression levels of rhoB mRNA by qRT-PCR *
Supplemental Figure S1 A B MDA-MB-231 MCF-7 BCL-2MDA-MB-231 BCL-2 MCF-7 Bcl-2 Actin Bcl-2 Actin.

Supplemental Figure S1 A B MDA-MB-231 MCF-7 BCL-2MDA-MB-231 BCL-2 MCF-7 Bcl-2 Actin Bcl-2 Actin.
Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V5 1 2 3 A B C ANXA1.

Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V A B C ANXA1.
Supplementary Figure S1 a

Supplementary Figure S1 a
Supplementary Figure S4

Supplementary Figure S4
Progesterone receptor

Progesterone receptor
Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.

Figure S1. qPCR analysis of the EMT markers ZEB2 and SNAI1 in Syndecan-1 and control siRNA transfected MDA-MB-231 and MCF-7 cells reveals no significant.
ABAE positive cells 6h after treatment

ABAE positive cells 6h after treatment

Similar presentations

Ads by Google